– A policitemia vera (PV) é uma doença mieloproliferativa crônica, caracterizada pela proliferação de precursores hematopoéticos, principalmente da série eritróide. Recentemente desenvolveram critérios para estabelecer o diagnóstico de Policitemia vera: categoria A – critérios maior e categoria B – critérios menores.

 

Is there a gender effect in polycythemia vera?

Francesca Palandri, Barbara Mora, Naseema Gangat, Lucia Catani

Ann Hematol. 2021; 100(1): 11–25

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7782364/

 

New perspectives on polycythemia vera: from diagnosis to therapy

Alessandra Iurlo, Daniele Cattaneo, Cristina Bucelli, Luca Baldini

Int J Mol Sci. 2020 Aug; 21(16): 5805

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7461104/

 

Rutolitinib-associated infections in polycythemia vera: review of the literature, clinical significance, and recommendations

Parvis Sadjadian, Kai Wille, Martin Griesshammer

Cancers (Basel) 2020 Nov; 12(11): 3132

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7693745/

 

Ruxolitinib for the prevention of thrombosis in new perspectives on polycythemia vera: from diagnosis to therapy

A Lurlo, D Cattaneo, C Bucelli, L Baldini

Int J Mol Sci 2020, vol 21 (16): 5805

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6988397/

 

Ruxolitinib for the prevention on thrombosis in polycythemia vera: a systematic review and meta-analysis

Arianna Masciulli, Alberto Ferrari, Alessandra Carobbio et al

Blood Adv. 2020 Jan 28; 4(2): 380–38

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6988397/

 

Patterns of hydroxyurea prescription and use in routine clinical management of polycythemia vera: a multicenter chart review study

Yahya Büyükaşık, Rıdvan Ali, Mehmet Turgut, et al

Turk J Haematol. 2020 Sep; 37(3): 177–18

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7463219/

 

Beyond hemoglobin: When and how to work up possible polycythemia vera

Gene Shaw, Richard Berg

Clin Med Res. 2020 Mar; 18(1): 11–20

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7153800/

 

Polycythemia vera-asociated complications: pathogenesis, clinical manifestations, and effects on outcomes

D Cuthbert, B L Stein

J Blood Med 2019, vol 10: 359-371

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6805785

 

 

Polycythemia vera management and challenges in the Commmunity Health Setting

G A T, Dao K H

Oncology 2017, vol 92: 179-189

https://www.karger.com/Article/Fulltext/454953

 

■  Dr Paulo Fernando Leite

Cardiologia/Prevenção Cardiovascular

Consultório: Rua Padre Rolim 815/sala 601 – Belo Horizonte/MG/Brasil

Tel: 33245518

CRMMG: 7026

Email: pfleite1873@gmail.com

Blog Internet Médica – www.internetmedica.com.br

Data: janeiro 2021